Clickable Table

< back to the main pricing table
Generic Name Brand Name Strength Dosing 90 Day Cost Coverage Comments Category 1 Category 2
Fluticasone furoate/Umeclidinium/Vilanterol Trelegy Ellipta (30) 100/62.5/25 mcg 1 pf qd $470 BC / NIHB - SA Respiratory Long-acting beta-agonist/long acting muscarinic antagonist/Corticosteroid Combos
Fluticasone Flovent (120) 250 mcg 1 pf bid $90 BC / NIHB - Covered Respiratory Corticosteroids
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Glycopyrronium Seebri (30) 50 mcg 1 pf qd $195 BC / NIHB - Covered Respiratory Bronchodilators / Anti-cholingergics
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Budesonide/Formoterol Symbicort (120) 200/6 mcg 1 pf qd $180 BC / NIHB - SA Respiratory Long-acting beta-agonist/Corticosteroid Combos
Beclomethasone Qvar (200) 100 mcg 1 pf bid $85 BC / NIHB - Covered Respiratory Corticosteroids
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Glycopyrronium/Indacaterol Ultibro (30) 50/110 mcg 1 pf qd $270 BC / NIHB - Covered Respiratory Long-acting Anti-cholinergic/Long-acting Beta-agonist Combos
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Salbutamol Ventolin (200) 100 mcg 4 pfs/d $25 BC / NIHB - Covered Respiratory Bronchodilators / Anti-cholingergics
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Ipratropium Atrovent (200) 200 mcg 1 pf qid $35 BC / NIHB - Covered Respiratory Bronchodilators / Anti-cholingergics
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Fluticasone Flovent (120) 125 mcg 1 pf bid $55 BC / NIHB - Covered Respiratory Corticosteroids
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Budesonide Pulmicort (200) 200 mcg 1 pf bid $90 BC / NIHB - Covered Respiratory Corticosteroids
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Fluticasone/Salmeterol Advair MDI (120) 250/25 mcg 1 pf bid $285 BC / NIHB - SA Respiratory Long-acting beta-agonist/Corticosteroid Combos
Montelukast Singulair 10 mg QD $55 BC - Restricted / NIHB - Covered Respiratory Leukotriene Receptor Antagonist
Tiotropium Spiriva (30) 18 mcg 1 pf qd $105 BC / NIHB - Covered Respiratory Bronchodilators / Anti-cholingergics
Puffers differ in their ‘doses’ (puffs) per device, so comparing costs is difficult. The 90 day cost was calculated by: 1. Determining the total number of doses over 90 days (using the stated dosing frequency). 2. Multiplying by the calculated cost per dose 3.Adding the dispensing fee and markup. This will not be exactly what patients pay for these products but allows for a more fair comparison between therapies. Brackets next to brand name indicate number of doses per device.
Fluticasone/Salmeterol Advair Diskus (60) 250/50 mcg 1 pf bid $180 BC / NIHB - SA Respiratory Long-acting beta-agonist/Corticosteroid Combos
Fluticasone/Vilanterol Breo Ellipta (30) 100/25 mcg 1 pf qd $335 BC / NIHB - SA Respiratory Long-acting beta-agonist/Corticosteroid Combos
Legend:
BC = Alberta Blue Cross, NIHB = Non-Insured Health Benefits for First Nations and Inuit, NC = Not covered, SA = special authorization